Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-01-04 Sale |
2021-01-06 4:41 pm |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
3,957 | $191.52 | $757,840 | 29,498 (Direct) |
View |
| 2020-12-16 Sale |
2020-12-18 4:30 pm |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
435 | $186.18 | $80,988 | 25,654 (Direct) |
View |
| 2020-11-19 Sale |
2020-11-23 7:03 pm |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
20,000 | $185.8 | $3,716,051 | 233,327 (Direct) |
View |
| 2020-11-11 Sale |
2020-11-13 4:46 pm |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
934 | $187.73 | $175,340 | 2,464 (Direct) |
View |
| 2020-11-09 Sale |
2020-11-10 9:18 pm |
REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director |
1,214 | $195.51 | $237,349 | 1,450 (Direct) |
View |
| 2020-11-09 Sale |
2020-11-10 9:17 pm |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
3,791 | $193.31 | $732,854 | 37,243 (Direct) |
View |
| 2020-09-10 Sale |
2020-09-14 07:43 am |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
45,351 | $148.2 | $6,721,018 | 253,327 (Direct) |
View |
| 2020-08-06 Sale |
2020-08-10 5:35 pm |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
5,000 | $153.79 | $768,950 | 31,939 (Direct) |
View |
| 2020-07-31 Sale |
2020-08-04 7:50 pm |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
3,095 | $151.9 | $470,129 | 1,464 (Direct) |
View |
| 2020-06-18 Sale |
2020-06-22 4:42 pm |
REPLIGEN CORP | RGEN | DAWES KAREN A Director |
18,705 | $115.2 | $2,154,851 | 100,734 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-01-25 Exercise |
2021-01-26 9:59 pm |
N/A 2028-03-01 |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
4,000 | $0 | 40,385 (Direct) |
View |
| 2021-01-25 Exercise |
2021-01-26 9:59 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
4,000 | $33.87 | 40,385 (Direct) |
View |
| 2020-11-19 Exercise |
2020-11-23 7:03 pm |
N/A 2026-02-26 |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
20,000 | $0 | 233,327 (Direct) |
View |
| 2020-11-19 Exercise |
2020-11-23 7:03 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
20,000 | $26.05 | 233,327 (Direct) |
View |
| 2020-11-11 Exercise |
2020-11-13 4:46 pm |
N/A N/A |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
934 | $38.76 | 2,464 (Direct) |
View |
| 2020-11-11 Exercise |
2020-11-13 4:46 pm |
N/A 2027-05-18 |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
934 | $0 | 2,464 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-10 9:17 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
1,893 | $59.52 | 37,243 (Direct) |
View |
| 2020-11-09 Exercise |
2020-11-10 9:17 pm |
N/A 2029-02-28 |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
4,979 | $0 | 37,243 (Direct) |
View |
| 2020-11-10 Exercise |
2020-11-10 9:17 pm |
N/A N/A |
REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer |
3,086 | $32.4 | 37,243 (Direct) |
View |
| 2020-09-10 Exercise |
2020-09-14 07:43 am |
N/A 2026-02-26 |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
45,351 | $0 | 253,327 (Direct) |
View |
| 2020-09-10 Exercise |
2020-09-14 07:43 am |
N/A N/A |
REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer |
45,351 | $26.05 | 253,327 (Direct) |
View |
| 2020-08-06 Exercise |
2020-08-10 5:35 pm |
N/A 2028-03-01 |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
5,000 | $0 | 31,939 (Direct) |
View |
| 2020-08-06 Exercise |
2020-08-10 5:35 pm |
N/A N/A |
REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP, R&D |
5,000 | $33.87 | 31,939 (Direct) |
View |
| 2020-07-31 Exercise |
2020-08-04 7:50 pm |
N/A N/A |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
2,109 | $67.71 | 1,464 (Direct) |
View |
| 2020-07-31 Option Award |
2020-08-04 7:50 pm |
N/A 2029-05-15 |
REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director |
2,109 | $0 | 1,464 (Direct) |
View |